---
figid: PMC6394415__nihms-1512135-f0001
figlink: /pmc/articles/PMC6394415/figure/F1/
number: F1
caption: 'The uremic toxin indoxyl sulfate accumulates in patients with chronic kidney
  disease on hemodialysis. Macrophages in atherosclerotic lesions take up indoxyl
  sulfate via OATP2B1. Indoxyl sulfate increases USP5 which inhibits the ubiquitin
  proteasome pathway. Dll4 levels increase due to impaired degradation and activate
  NOTCH receptors on macrophages in proximity. NOTCH-ICD translocates into the nucleus
  and induces transcription of proinflammatory cytokines, which further aggravate
  atherosclerotic lesion development. OATP2B1: Organic anion transporting polypeptide
  P2B1. USP5: Ubiquitin specific peptidase 5. UPP: Ubiquitin proteasome pathway. Dll4:
  Delta-like ligand 4. ICD: Intracellular domain. IL1β: Interleukin 1-beta. MCP1:
  Monocyte chemoattractant protein 1.'
pmcid: PMC6394415
papertitle: 'Uremic toxins activate macrophages: implications for atherosclerosis
  in chronic kidney disease.'
reftext: Friedrich F. Hoyer, et al. Circulation. 2019 Jan 2;139(1):97-100.
pmc_ranked_result_index: '93675'
pathway_score: 0.9714697
filename: nihms-1512135-f0001.jpg
figtitle: The uremic toxin indoxyl sulfate accumulates in patients with chronic kidney
  disease on hemodialysis
year: '2019'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6394415__nihms-1512135-f0001.html
  '@type': Dataset
  description: 'The uremic toxin indoxyl sulfate accumulates in patients with chronic
    kidney disease on hemodialysis. Macrophages in atherosclerotic lesions take up
    indoxyl sulfate via OATP2B1. Indoxyl sulfate increases USP5 which inhibits the
    ubiquitin proteasome pathway. Dll4 levels increase due to impaired degradation
    and activate NOTCH receptors on macrophages in proximity. NOTCH-ICD translocates
    into the nucleus and induces transcription of proinflammatory cytokines, which
    further aggravate atherosclerotic lesion development. OATP2B1: Organic anion transporting
    polypeptide P2B1. USP5: Ubiquitin specific peptidase 5. UPP: Ubiquitin proteasome
    pathway. Dll4: Delta-like ligand 4. ICD: Intracellular domain. IL1β: Interleukin
    1-beta. MCP1: Monocyte chemoattractant protein 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCL2
  - NOTCH4
  - NOTCH2
  - NOTCH3
  - NOTCH1
  - SLCO2B1
  - Indoxyl sulfate
  - Chronic kidney disease
  - Atherosclerotic lesion
  - ICD
genes:
- word: MCP1
  symbol: MCP-1
  source: hgnc_alias_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: NOTCH
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
- word: NOTCH
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: NOTCH
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: NOTCH
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: OATP2B1
  symbol: OATP2B1
  source: hgnc_alias_symbol
  hgnc_symbol: SLCO2B1
  entrez: '11309'
chemicals:
- word: Indoxyl sulfate
  source: MESH
  identifier: D007200
diseases:
- word: Chronic kidney disease
  source: MESH
  identifier: D051436
- word: Atherosclerotic lesion
  source: MESH
  identifier: D050197
- word: ICD
  source: OMIM
  identifier: '252500'
figid_alias: PMC6394415__F1
redirect_from: /figures/PMC6394415__F1
figtype: Figure
---
